SunBird Bio, Inc. — Form D

SunBird Bio, Inc. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-12. The offering totals $23.2M, of which $23.2M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (24)

NameRoleLocation
Alexandra CantleyDirectorNewton, MA
Steve KafkaDirectorSan Mateo, CA
Stanley LapidusDirectorBOSTON, MA
John McDonoughDirectorNew York, NY
HUILIN SHAODirectorCAMBRIDGE, MA
YINGMIN WANGDirectorCAMBRIDGE, MA
Amy SchulmanDirectorCambridge, MA
Robert LangerDirectorPittsburgh, PA
Sirshendu Roopom BanerjeeExecutive OfficerWoburn, MA
Theresia GouwDirectorSan Francisco, CA
George ZacharyDirectorSan Francisco, CA
Caroline LoewDirectorBoston, MA
Caroline LoewExecutive OfficerBoston, MA
Francis CussDirectorCambridge, MA
Tram Winckler TranExecutive OfficerCambridge, MA
Wendy Winckler AdamovichExecutive OfficerCambridge, MA
Jessica Winckler AtkinsonExecutive OfficerCambridge, MA
Dhaval Winckler GosaliaExecutive OfficerCambridge, MA
Matthew Winckler NavarroExecutive OfficerCambridge, MA
Tracey DawsonExecutive OfficerCambridge, MA
Theresia Roopom GuowDirectorCambridge, MA
Gabriel KwongExecutive OfficerCambridge, MA
Stan Roopom LapidusDirectorCambridge, MA
Amy Roopom SchulmanDirectorCambridge, MA

Other filings by this issuer (4)

FiledFormOfferingSold
2021-12-17D$18.0M$18.0M
2021-07-01D/A$46.7M$46.7M
2020-06-12D$45.0M$26.1M
2018-08-06D$30.1M$26.1M

More